FR173657 structure
|
Common Name | FR173657 | ||
---|---|---|---|---|
CAS Number | 167838-64-4 | Molecular Weight | 592.47 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C30H27Cl2N5O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of FR173657FR173657 is an orally active bradykinin B2 receptor antagonist (IC50: 0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively). FR173657 (p.o.) inhibits BK-induced bronchoconstriction in guinea-pigs (ED50: 0.075 mg/kg). FR173657 (p.o.) also inhibits Carrageenin-induced paw oedema in mice (ED50: 6.8 mg/kg). FR173657 can be used for research of inflammatory disease[1]. |
Name | FR173657 |
---|
Description | FR173657 is an orally active bradykinin B2 receptor antagonist (IC50: 0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively). FR173657 (p.o.) inhibits BK-induced bronchoconstriction in guinea-pigs (ED50: 0.075 mg/kg). FR173657 (p.o.) also inhibits Carrageenin-induced paw oedema in mice (ED50: 6.8 mg/kg). FR173657 can be used for research of inflammatory disease[1]. |
---|---|
Related Catalog | |
Target |
0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively[1] |
References |
Molecular Formula | C30H27Cl2N5O4 |
---|---|
Molecular Weight | 592.47 |